Time Course Profile of Adverse Events of Interest and Serious Adverse Events With Darolutamide in the ARAMIS Trial

被引：0

作者：

Grabbert, Markus ^{[1
]}

Gratzke, Christian ^{[1
]}

Fizazi, Karim ^{[2
]}

Shore, Neal ^{[3
]}

Smith, Matthew ^{[4
]}

Feyerabend, Susan ^{[5
]}

Carles, Joan ^{[6
]}

Lebret, Thierry ^{[7
]}

Vjaters, Egils ^{[8
]}

Werbrouck, Patrick ^{[9
]}

Miskic, Marina ^{[10
]}

Schmall, Anja ^{[11
]}

Le Berre, Marie Aude ^{[12
]}

Borghesi, Gustavo ^{[13
]}

Verholen, Frank ^{[14
]}

机构：

[1] Univ Hosp Freiburg, Freiburg, Germany

[2] Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France

[3] Carolina Urol Res Ctr, Myrtle Beach, SC USA

[4] Massachusetts Gen Hosp, Boston, MA USA

[5] Studienpraxis Urol, Nuertingen, Germany

[6] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Barcelona, Spain

[7] Hop Foch, Suresnes, France

[8] P Stradins Clin Univ Hosp, Riga, Latvia

[9] AZ Groeninge, Kortrijk, Belgium

[10] Bayer Consumer Care AG, Basel, Switzerland

[11] Bayer Vital GmbH, Leverkusen, Germany

[12] Bayer Healthcare SAS, Loos, France

[13] Bayer AG, Berlin, Germany

[14] Bayer Healthcare SAS, Basel, Switzerland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

327

引用

页码：105 / 105

页数：1

共 50 条

[31] Serious suspected adverse events associated with Gardasil
Reactions Weekly, 2010, 1293 (1) : 1 - 1
[32] Serious adverse events due to aminosalicylate therapy
Gibson, P. R.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A318 - A318
[33] Acupuncture may be associated with serious adverse events
Ernst, E
White, AR
BRITISH MEDICAL JOURNAL, 2000, 320 (7233): : 513 - 514
[34] Serious adverse events after cataract surgery
Stein, Joshua D.
CURRENT OPINION IN OPHTHALMOLOGY, 2012, 23 (03) : 219 - 225
[35] Finasteride/tamsulosin: no serious, unexpected adverse events
Reactions Weekly, 2001, 865 (1) : 3 - 3
[36] Frequency of serious psychiatric adverse events with efavirenz
Allin, M
Reeves, I
Tennant-Flowers, M
Everall, I
ANTIVIRAL THERAPY, 2003, 8 (04) : L85 - L86
[37] THE LIVERPOOL ADVERSE DRUG EVENTS PROFILE
BAKER, GA
JACOBY, A
FRANCIS, P
CHADWICK, DW
EPILEPSIA, 1995, 36 : S59 - S59
[38] A REVIEW OF THE ADVERSE EVENTS PROFILE OF CEFPIROME
RUBINSTEIN, E
LABS, R
REEVES, A
DRUG SAFETY, 1993, 9 (05) : 340 - 345
[39] Using historical RCT controls to contextualize necessity of unblinding of serious adverse events and adverse events of special interest-Conceptual framework and database development
Schneiderman, Chris
Kracht, Karolyn
Patel, Gunjan
Chatni, Muhammad R.
Mintri, Ritesh
Liede, Alexander
Kilpatrick, Ryan D.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 445 - 445
[40] Never Events in Radiology and Strategies to Reduce Preventable Serious Adverse Events
Flug, Jonathan A.
Ponce, Lisa M.
Osborn, Howard H.
Jokerst, Clinton E.
RADIOGRAPHICS, 2018, 38 (06) : 1823 - 1832

← 1 2 3 4 5 →